HOMA-IR as well as concentrations of glucose, HbA1c, and insulin improved in both groups (P < .001); statistically significantly more so in patients with T2D (P < .001 for the interaction term for all except for insulin, where the decrease did not differ between groups). The gene discussed is INS; the disease is type 2 diabetes mellitus.